fashion -WSS

fashion

author：hotspot 2025-09-27 12:47:25 - browse：1

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： HCA says smaller share of spending going to labor

explore

focus

WSS

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Doctors in states that ban abortion can still help patients

5 wounded, 2 critically, in Michigan shopping center shooting

HCA says smaller share of spending going to labor

Doctors increasingly discourage vaping amid mounting health concerns

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

explore

fashion

explore

After affirmative action ruling, medical educators look to 'holistic review'

FDA approves Sage Therapeutics’ rapid

Activists slam private health insurers over coverage restrictions

Medicare slashes safety net hospital payments by nearly $1 billion

Activists slam private health insurers over coverage restrictions

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

23andMe had bad news about my health. I wish a person had delivered it

Late stage cancers on the rise after pandemic delayed screenings

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

2 officers injured in shooting in Orlando, police say

focus

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Physicians aren't 'burning out.' They're suffering from moral injury

Medicare slashes safety net hospital payments by nearly $1 billion

House GOP plan to stem drug shortages differs from Democrats’

A controversial new treatment promises to make little people taller

5 wounded, 2 critically, in Michigan shopping center shooting

explore

focus

explore

hotspot